IN FOUR DAYS: Enjoy an audience with Gervais Williams (AND the cheapest stock on AIM) - book a free seat now
Tom Winnifrith Bearcast - Being a Purplebricks bull must be enough, I'd imagine, to turn a man to drink
AIM-listed Midatech (MTPH) is a cancer-busting company which uses its Q-Sphera technology which, according to Proative Investors, works in a different way to deliver the drug at the right time. Ah, so we have a disruptive cancer-buster…..step forward Neil Woodford, who backed the IPO back in 2014 (at 267p vs share price now just 3.4p!) and ponied up to support placings along the way. Oh dear. But it gets worse……although the PR comedy this morning makes up for it!
In this case the turd has been sugared, the pill polished but make no mistake, Midatech Pharma (MTPH) is well in the merde and that is bad news for Britain’s most conceited fund manager Neil Woodford whose funds own 20% of the equity.
I have to say I haven’t come across AIM-listed Midatech (MTPH) until now. However, with interims results just released perhaps I could get a handle on it. The problem is that the interim report has a few gaping holes in it, all of which leaves a strong sense of unease. The unease in increased when I note that the recent bailout placing (at a whopping 31% discount) showed up Woodford Investment Management as a major holder. Oh dear, not a good start….
Search ShareProphets |
Recent Comments |